The current price of 207940.KS is ₩1,520,000 — it has increased by 1.67% since the previous close. Data as of Nov 5, 2026.
207940.KS is up 10.14% over the past week, up 16.03% over the past month and down 19.03% over the past year. The price is above its 200-day moving average of ₩1,502,196.
Of the 27 analysts covering Samsung Biologics Co.,Ltd., 10 rate it a strong buy, 14 rate it a buy and 3 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Samsung Biologics Co.,Ltd. has a market capitalization of ₩70.76T. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Samsung Biologics Co.,Ltd. posted earnings of ₩8,448.73 per share against an estimate of ₩9,799.29, missing expectations by 13.78%. Upcoming reports are listed in the earnings calendar.
Samsung Biologics Co.,Ltd. reported revenue of ₩1.49T in its most recent quarter, which has increased by 17.29% compared with the same quarter a year earlier. Analysts had expected ₩1.36T.
207940.KS trades at a price-to-earnings ratio of 39.1 based on its earnings over the last twelve months.
Samsung Biologics Co.,Ltd. has not paid any dividends over the past year.
Companies most comparable to Samsung Biologics Co.,Ltd. include Celltrion, Inc., Biocon Limited, WuXi AppTec Co., Ltd., Prestige BioPharma Limited and WuXi Biologics (Cayman) Inc.
In the latest trading session 207940.KS moved between ₩1,512,000 and ₩1,575,000, a range of 4.14% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Samsung Biologics Co.,Ltd. shows a strong buy rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Samsung Biologics Co.,Ltd. is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks 207940.KS has traded between ₩1,150,000 and ₩1,987,000. The current price is 23.50% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.